SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-0.19%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$339M
AUM Growth
+$339M
(+59%)
Cap. Flow
+$135M
Cap. Flow
% of AUM
39.85%
Top 10 Holdings %
Top 10 Hldgs %
57.87%
Holding
181
New
46
Increased
26
Reduced
25
Closed
28
Top Buys
| 1 |
Weyerhaeuser
WY
|
$64.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$34M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$8.75M |
| 4 |
AGN
Allergan plc
AGN
|
$7.45M |
| 5 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$5.83M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$11M |
| 2 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$8.78M |
| 3 |
Sarepta Therapeutics
SRPT
|
$6.71M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$6.23M |
| 5 |
Thermo Fisher Scientific
TMO
|
$4.65M |
Sector Composition
| 1 | Healthcare | 64.94% |
| 2 | Real Estate | 19.41% |
| 3 | Energy | 2.49% |
| 4 | Consumer Discretionary | 1.61% |
| 5 | Communication Services | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Weyerhaeuser
WY
$18.7B
| $64.6M | 2.77% | +1,950,977 | New | +$64.6M |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $53.1M | 2.28% | 1,013,302 +648,561 | +178% | +$34M |
|
|
3
Regeneron Pharmaceuticals
REGN
$61.5B
| $13.6M | 0.58% | 48,177 +30,986 | +180% | +$8.75M |
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $13.3M | 0.57% | 589,264 +126,118 | +27% | +$2.85M |
|
5
Tenax Therapeutics
TENX
$27.3M
| $11.1M | 0.48% | 2,722,929 +602,175 | +28% | +$2.46M |
|
6
Opko Health
OPK
$1.1B
| $10.6M | 0.45% | 1,193,955 +362,718 | +44% | +$3.21M |
|
|
IOC
7
DELISTED
Interoil Corporation
IOC
| $8.43M | 0.36% | 131,794 +89,433 | +211% | +$5.72M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $7.45M | 0.32% | +33,376 | New | +$7.45M |
|
|
CDMO
9
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $7.03M | 0.3% | 291,600 +53,191 | +22% | +$1.28M |
|
10
Sangamo Therapeutics
SGMO
$157M
| $6.77M | 0.29% | 443,286 +266,021 | +150% | +$4.06M |
|
|
SLXP
11
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $6.09M | 0.26% | 49,403 +47,233 | +2,177% | +$5.83M |
|
12
Amgen
AMGN
$155B
| $5.88M | 0.25% | 49,703 +7,392 | +17% | +$875K |
|
13
Tesla
TSLA
$1.08T
| $5.18M | 0.22% | +21,557 | New | +$5.18M |
|
|
QPAC
14
DELISTED
QUINPARIO ACQUISITION CORP COM STK
QPAC
| $4.84M | 0.21% | +461,756 | New | +$4.84M |
|
|
THMO
15
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $4.61M | 0.2% | 3,317,805 +2,788,507 | +527% | +$3.88M |
|
|
AKTX
16
Akari Therapeutics
AKTX
$24.8M
| $4.51M | 0.19% | 819,911 +150,831 | +23% | +$830K |
|
17
Plus Therapeutics
PSTV
$45.3M
| $4.29M | 0.18% | +1,795,963 | New | +$4.29M |
|
|
BLRX
18
BioLineRX
BLRX
$16.2M
| $4.2M | 0.18% | 2,021,347 +118,547 | +6% | +$247K |
|
19
AstraZeneca
AZN
$248B
| $4.18M | 0.18% | +56,275 | New | +$4.18M |
|
|
20
Sarepta Therapeutics
SRPT
$1.78B
| $3.78M | 0.16% | 126,772 -225,328 | -64% | -$6.71M |
|
|
DRNA
21
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.45M | 0.15% | 152,994 +101,484 | +197% | +$2.29M |
|
22
Achieve Life Sciences
ACHV
$152M
| $3.44M | 0.15% | +922,562 | New | +$3.44M |
|
23
MacroGenics
MGNX
$112M
| $3.26M | 0.14% | 149,839 -714 | -0.5% | -$15.5K |
|
24
uniQure
QURE
$896M
| $3.06M | 0.13% | 225,081 -128,919 | -36% | -$1.75M |
|
|
PARA
25
DELISTED
Paramount Global Class B
PARA
| $2.99M | 0.13% | +48,100 | New | +$2.99M |
|